CHRONIC KIDNEY DISEASE (STAGE 3)
Clinical trials for CHRONIC KIDNEY DISEASE (STAGE 3) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC KIDNEY DISEASE (STAGE 3) trials appear
Sign up with your email to follow new studies for CHRONIC KIDNEY DISEASE (STAGE 3), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Kidney-Liver drug trial halted early – what happened?
Disease control TerminatedThis small Phase 2 study tested two doses of vonafexor, an oral drug, in 10 people with mild-to-moderate chronic kidney disease and suspected MASH (a type of fatty liver disease). The goal was to see if vonafexor could improve kidney function. However, the trial was terminated ea…
Matched conditions: CHRONIC KIDNEY DISEASE (STAGE 3)
Phase: PHASE2 • Sponsor: Enyo Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New Heart-Kidney combo drug tested in tiny study
Disease control TerminatedThis early study tested a new drug called AZD5462 added to the standard medicine dapagliflozin in people with heart failure and moderate kidney disease. Only 8 participants were enrolled before the study was stopped. The goal was to see if the combination is safe and affects how …
Matched conditions: CHRONIC KIDNEY DISEASE (STAGE 3)
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC